Skip to main content

Closed

ABBV: AbbVie Inc. Stock Analysis | finqOS

Healthcare · Drug Manufacturers - General

Loading chart data...

Current StateBalance holding

The verdict

Good business

Strong

Revenue growth+8.6% / yr

Operating margin27.6%

ROIC10.3%

Financially safe

Strong

Debt / equity-10.95×

Interest coverage6.0×

Current ratio0.80×

Valuation

Unrated

P/E ratio123.0×

Dividend yield2.7%

AbbVie Inc.

ABBVNew York Stock Exchange·USD·Closed

AbbVie Inc.

ABBVNew York Stock Exchange·USD·Closed

$250.88

−2.54%

$250.88

−$6.54 (2.54%)

52W Range

79thpctl

Volume

0.72×avg

Mkt Cap

443.24BUSD

P/E

123.0TTM

Div Yield

2.72%ann

52W Range

79thpctl

Volume

0.72×avg

Market Cap

443.24BUSD

P/E Ratio

123.0TTM

Div Yield

2.72%ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings